Mikrobiomik Healthcare Company S.L.

3 trials 1 recruiting Commercial sponsor

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

4 Unique IMPs

N/A Results reported

Phase II

Top indications

Non-alcoholic steatohepatitis 2

Top IMPs

ALLOGENEIC FAECAL MICROBIOTA, POOLED 3

All trials

3 total

Study of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis Pending

2022-500185-94-01 Phase II 1 country ALLOGENEIC FAECAL MICROBIOTA, POOLED
Clinical trial with MBK-01, intestinal microbiota capsules, for the treatment of patients with recurring diverticulitis Recruiting

2023-506224-87-00 Phase II 1 country ALLOGENEIC FAECAL MICROBIOTA, POOLED
Study of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis Expired

2022-500185-94-00 Phase II 1 country ALLOGENEIC FAECAL MICROBIOTA, POOLED

Showing 1–3 of 3 trials

← All sponsors A–Z